About OrthoSpace
OrthoSpace is a Healthcare company based in Caesarea (Israel) founded in 2009 by Assaf Dekel, and was acquired by Stryker in March 2019. It operates as a biodegradable balloon system for rotator cuff tear. OrthoSpace has raised $23.6 million across 5 funding rounds from investors including Stryker, Smith & Nephew and HealthpointCapital. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its competitors include Miach Orthopaedics, Rotation Medical, Cayenne Medical, Biorez and Nanochon and 4 more; 9 of its 9 listed competitors have raised funding.
Company details
OrthoSpace develops and commercializes a biodegradable balloon system, InSpace, which is deployed using minimally invasive techniques. The shoulder is a complicated joint that requires the interconnected functioning of tendons, ligaments and bones. The InSpace Balloon, which is implanted between the acromion and the humeral head, creates a space between the bone structures(acromion and humeral head), allowing smooth and frictionless gliding. The system is designed to create a physical barrier between tissues in the subacromial space. The company claims that the InSpace biodegradable balloon system emulates the activity of the normal bursa and offers patients less pain, and a shorter rehabilitation period. As of 2016, The InSpace System has the CE mark and is commercially available in Europe.
- Headquarters Caesarea, Israel
- Founders Assaf Dekel
- Stage Acquired
- SectorsHealthcare
- Website orthospace.co.il
- Social LinkedIn
- Acquired by Stryker (Mar 2019)
Funding Insights of OrthoSpace
OrthoSpace has successfully raised a total of $23.6M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $7 million completed in December 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $23.6M
- Total Rounds 5
- Last Round Series B — $7M
- First Round $1M
(Sep 2009)
- Investors Count 4
All 5 funding rounds of OrthoSpace with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2016 | $7M | Series B | – | – | |
| May 2015 | $8M | Series B | – | – | |
| Jul 2013 | $5M | Series B | – | – | |
| May 2011 | $2.6M | Series A | – | – | |
| Sep 2009 | $1M | Seed | – | – | – |
5 investors in total: 5 institutional.
Investors in OrthoSpace
OrthoSpace has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Stryker, Smith & Nephew and HealthpointCapital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
HealthpointCapital is focused on private equity in musculoskeletal healthcare. | – | healthpointcapital.com | San Diego, United States | |
Venture capital firm investing in early stage healthcare startups | – | triventures.vc | Herzliya, Israel | |
Manufacturer of knee, hip and shoulder joint replacements | 1856 | smith-nephew.com | London, United Kingdom | |
- | – | jnjinnovation.com | - | |
3D-printed orthopedic products are manufactured for medical applications. | 1941 | stryker.com | Kalamazoo, United States |
Investor details for OrthoSpace
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of OrthoSpace
1 people are tracked at OrthoSpace (1 in leadership).
| Name | Role | Group |
|---|---|---|
Assaf Dekel | Co-Founder | Leadership |
Complete people profiles for OrthoSpace
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of OrthoSpace
4 dated milestones of OrthoSpace across 10 years, from founding to its latest funding, stage changes and deals.
- Founded OrthoSpace is founded.
- Funding First funding round of $1.0M.
- Funding Latest funding round, Series B, of $7.0M.
- Exit Acquired by Stryker.
Competitors of OrthoSpace
OrthoSpace has 9 listed competitors in our database, 9 of them funded. They include Miach Orthopaedics, Rotation Medical, Cayenne Medical, Biorez and Nanochon, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| miachortho.com | 2016 | Boston, United States | $72.5M | – | Bio-engineered surgical implants for connective tissue repair are developed. | |
| rotationmedical.com | 2009 | Minneapolis, United States | $54.58M | 34 | A rotator cuff repair system is developed for disease treatment. | |
| cayennemedical.com | 2005 | Phoenix, United States | $46.3M | 54 | Soft tissue reconstruction solutions for knee and shoulder | |
| biorez.com | 2008 | New Haven, United States | $49.11M | – | Bioresorbable scaffolds for ACL soft tissue regeneration are developed. | |
| nanochon.com | 2016 | Burke, United States | $6M | – | 3D-printed implants are developed for treating joint injuries. | |
| embody-inc.com | 2014 | Norfolk, United States | $41.4M | 25 | Collagen-based regenerative matrices for soft tissue repair are provided. | |
| orthogenrx.com | 2012 | Doylestown, United States | $1.19M | 1,522 | Generic Class III medical devices in orthopedics are developed. | |
| tenexhealth.com | 2009 | Lake, United States | $18.52M | 34 | Minimally invasive therapies are provided for diseased tendon removal. | |
| zurimed.com | 2015 | Zurich, Switzerland | $16.7M | – | Ligament reconstruction devices are developed by ZuriMED Technologies. |
Detailed competitors of OrthoSpace
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Orthopedics
10 companies that operate in the same segment as OrthoSpace (Orthopedics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Prosthetic and orthotic devices are developed for individuals with disabilities. | 1919 | Duderstadt, Lower Saxony, Germany | USD 17 M | USD 1.97 B | 4,125 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Developer of drugs for treating rare and autoimmune diseases | 2008 | Dublin, Ireland | USD 61.78 M | USD 617.41 M | – | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Robotic arms are provided for mobility and rehabilitation support. | 2004 | Boston, Massachusetts, United States | USD 17.21 M | USD 40.93 M | 185 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608.25 M | – | 197 | |
Exoskeletons for medical rehabilitation and industrial productivity are provided. | 2005 | United States | USD 24.37 M | USD 71.6 M | 61 | |
Stabilization devices for healthcare are manufactured by the company. | 2005 | New York, New York, United States | USD 142.15 M | – | 43 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Orthospace
Complete news archive for OrthoSpace
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OrthoSpace
OrthoSpace was founded in 2009.
OrthoSpace is headquartered in Caesarea, Israel. It is registered at Caesarea, Haifa, Israel.
OrthoSpace is a funded company, having raised a total of $23.6M across 5 funding rounds to date. The company's 1st funding round was a Seed of $1M, raised on Sep 2009.
OrthoSpace develops and commercializes a biodegradable balloon system, InSpace, which is deployed using minimally invasive techniques. The shoulder is a complicated joint that requires the interconnected functioning of tendons, ligaments and bones. The InSpace Balloon, which is implanted between the acromion and the humeral head, creates a space between the bone structures(acromion and humeral head), allowing smooth and frictionless gliding. The system is designed to create a physical barrier between tissues in the subacromial space. The company claims that the InSpace biodegradable balloon system emulates the activity of the normal bursa and offers patients less pain, and a shorter rehabilitation period. As of 2016, The InSpace System has the CE mark and is commercially available in Europe.
OrthoSpace's top competitors include Miach Orthopaedics, Nanochon and ZuriMED Technologies.
OrthoSpace has 5 investors. Key investors include Stryker, Smith & Nephew, HealthpointCapital, Johnson & Johnson Innovation, and Triventures.
Yes. OrthoSpace was acquired by Stryker in March 2019.